Journal of Inherited Metabolic Disease logo Springer logo

Publisher: Springer

Volume 27, Number 3, 2004
Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

< previous issue | next issue > | all issues

Preface
pp. 303-304(2)

After the genome—the phenome?
pp. 305-317(13)
Author: Scriver C.R.

Retrotransposon-derived elements in the mammalian genome: A potential source of disease
pp. 319-330(12)
Authors: Druker R.; Whitelaw E.

The genetics and pathophysiology of diabetes mellitus type II
pp. 331-347(17)
Authors: Jenkins A.B.; Campbell L.V.

Mitochondrial disorders: Prevalence, myths and advances
pp. 349-362(14)
Author: Thorburn D.R.

Protein substitutes for PKU: What's new?
pp. 363-371(9)
Authors: Macdonald A.; Daly A.; Davies P.; Asplin D.; Hall S.K.; Rylance G.; Chakrapani A.

Hepatocyte transplantation for inborn errors of metabolism
pp. 373-383(11)
Author: Burlina A.B.

Enzyme replacement and enhancement therapies for lysosomal diseases
pp. 385-410(26)
Author: Desnick R.J.

Treatment of lysosomal storage disorders: Cell therapy and gene therapy
pp. 411-415(5)
Authors: Eto Y.; Shen J.-S.; Meng X.-L.; Ohashi T.

Glycine encephalopathy (nonketotic hyperglycinaemia): Review and update
pp. 417-422(6)
Authors: Applegarth D.A.; Toone J.R.

Congenital disorders of glycosylation (CDG): Update and new developments
pp. 423-426(4)
Author: Jaeken J.

< previous issue | next issue > | all issues

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A